Table_1_Cannabis Use Is Associated With Lower COVID-19 Susceptibility but Poorer Survival.PDF
To investigate the impact of cannabis use on the infection and survival outcomes of COVID-19.
Study DesignCross-sectional study based on the UK Biobank (UKB) dataset.
MethodsWe identified 13,099 individuals with cannabis smoking history in the UKB COVID-19 Serology Study. The Charlson-Quan Comorbidity Index was estimated using inpatient ICD-10 records. Multivariable logistic regression characterized features associated with COVID-19 infection. Cox models determined the hazard ratios (HR) for COVID-19-related survival.
ResultsCannabis users were more likely to getting COVID-19 (odds ratio: 1.22, P = 0.001) but multivariable analysis showed that cannabis use was a protective factor of COVID-19 infection (adjusted odds ratio: 0.81, P = 0.001). Regular cannabis users, who smoked more than once per month, had a significantly poorer COVID-19-related survival, after adjusting for known risk factors including age, gender, smoking history, and comorbidity (adjusted hazard ratio: 2.81, P = 0.041).
ConclusionsThe frequency of cannabis use could be considered as a candidate predictor for mortality risk of COVID-19.
History
Usage metrics
Categories
- Aboriginal and Torres Strait Islander Health
- Aged Health Care
- Care for Disabled
- Community Child Health
- Environmental and Occupational Health and Safety
- Epidemiology
- Family Care
- Health and Community Services
- Health Care Administration
- Health Counselling
- Health Information Systems (incl. Surveillance)
- Health Promotion
- Preventive Medicine
- Primary Health Care
- Public Health and Health Services not elsewhere classified
- Medicine, Nursing and Health Curriculum and Pedagogy
- Nanotoxicology, Health and Safety
- Mental Health Nursing
- Midwifery
- Nursing not elsewhere classified